Kuros Biosciences AG Statistics

Total Valuation

CSBTF has a market cap or net worth of 1.35 billion. The enterprise value is 1.33 billion.

Market Cap	1.35B
Enterprise Value	1.33B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	38.37M
Shares Outstanding	n/a
Shares Change (YoY)	+3.76%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	26.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.23
PB Ratio	20.87
P/TBV Ratio	50.42
P/FCF Ratio	599.68
P/OCF Ratio	390.56
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-281.57
EV / Sales	14.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	590.68

Financial Position

The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.03.

Current Ratio	2.14
Quick Ratio	1.63
Debt / Equity	0.03
Debt / EBITDA	0.66
Debt / FCF	0.88
Interest Coverage	0.72

Financial Efficiency

Return on equity (ROE) is -6.44% and return on invested capital (ROIC) is 0.11%.

Return on Equity (ROE)	-6.44%
Return on Assets (ROA)	0.09%
Return on Invested Capital (ROIC)	0.11%
Return on Capital Employed (ROCE)	0.17%
Revenue Per Employee	683,422
Profits Per Employee	-38,805
Employee Count	122
Asset Turnover	0.97
Inventory Turnover	1.18

Taxes

In the past 12 months, CSBTF has paid 408,307 in taxes.

Income Tax	408,307
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +176.24% in the last 52 weeks. The beta is 0.69, so CSBTF's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	+176.24%
50-Day Moving Average	30.47
200-Day Moving Average	25.81
Relative Strength Index (RSI)	76.90
Average Volume (20 Days)	591

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSBTF had revenue of 83.38 million and -4.73 million in losses. Loss per share was -0.13.

Revenue	83.38M
Gross Profit	74.08M
Operating Income	118,078
Pretax Income	-3.69M
Net Income	-4.73M
EBITDA	2.27M
EBIT	118,078
Loss Per Share	-0.13

Full Income Statement

Balance Sheet

The company has 19.89 million in cash and 1.98 million in debt, giving a net cash position of 17.91 million.

Cash & Cash Equivalents	19.89M
Total Debt	1.98M
Net Cash	17.91M
Net Cash Per Share	n/a
Equity (Book Value)	64.83M
Book Value Per Share	1.71
Working Capital	26.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.47 million and capital expenditures -1.21 million, giving a free cash flow of 2.26 million.

Operating Cash Flow	3.47M
Capital Expenditures	-1.21M
Free Cash Flow	2.26M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 88.85%, with operating and profit margins of 0.14% and -5.68%.

Gross Margin	88.85%
Operating Margin	0.14%
Pretax Margin	-4.43%
Profit Margin	-5.68%
EBITDA Margin	2.72%
EBIT Margin	0.14%
FCF Margin	2.71%

Dividends & Yields

CSBTF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.76%
Shareholder Yield	n/a
Earnings Yield	-0.35%
FCF Yield	0.17%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CSBTF has an Altman Z-Score of 11.67 and a Piotroski F-Score of 5.

Altman Z-Score	11.67
Piotroski F-Score	5